“Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-04 · 18 (2)
DOI: 10.1002/dad2.70373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 17.06.2026. Verfasst von Eric Dinnerstein. Beteiligte Einrichtung: UT Tyler Neurology Department The University of Texas Tyler Dementia Center Tyler Texas USA. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The approval of lecanemab and donanemab represents a watershed moment in Alzheimer Disease (AD) treatment, yet clinicians face a novel challenge: guiding patients through treatment selection when head‐to‐head comparative data are absent. When confronted with the question “What would you do if you were me?”, clinical providers must balance evidence‐based medicine with the therapeutic alliance. This perspective examines the ethical, practical, and relational dimensions of responding to personal preference queries in the context of anti‐amyloid immunotherapy selection, offering a framework for authentic engagement that honors both professional boundaries and patient‐centered care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UT Tyler Neurology Department The University of Texas Tyler Dementia Center Tyler Texas USA.
Zitieren
APA
Dinnerstein, E. (2026). “Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(2). https://doi.org/10.1002/dad2.70373
Vancouver
Dinnerstein E. “Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(2). doi:10.1002/dad2.70373
BibTeX
@article{Dinnerstein2026,
author = {Dinnerstein, Eric},
title = {“Doctor, if it were you, which would you choose?”: Navigating personal preference questions in anti‐amyloid immunotherapy selection},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2026},
volume = {18},
number = {2},
doi = {10.1002/dad2.70373}
}
EUVIMED